EULAR updates PRP guidelines: Enhancing patient involvement in rheumatic disease research

FHS
June 18, 2024
6:01 am

In recent years, the benefits of involving PRPs has increasing been recognized. The role is an important one, which goes well beyond the inclusion of patients as study participants.

TLDR – TDR News highlights – February 12th to 13th

Get a quick update on today’s essential news! We’ve condensed the most important information about Cannabis, Psychedelics, Crypto, and AI into a brief format, saving

February 13, 2024

MS Disease Severity Tied to Genetic Variant

The first genetic variant associated with faster disease progression in multiple sclerosis (MS) has been identified. In a genome-wide association study (GWAS) of 22,000 people

June 29, 2023

Graphite founder takes drug to recently-launched Kamau Therapeutics for a second chance: #ASH23

SAN DIEGO — After Graphite Bio’s implosion, Matthew Porteus wants to do things differently. The Stanford researcher’s stint at the biotech ended with Graphite selling

December 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.